According to Mengke Pharmaceutical's announcement, the company's shareholder BestIdea plans to reduce its holdings by no more than 19.68,900 shares, accounting for 3% of the total share capital; shareholders JSR and GPTMT, acting as concerted actors, plan to reduce their holdings by no more than 19668,200 shares, accounting for 3% of the total share capital.

According to Mengke Pharmaceutical's announcement, the company's shareholder BestIdea plans to reduce its holdings by no more than 19.68,900 shares, accounting for 3% of the total share capital; shareholders JSR and GPTMT, acting as concerted actors, plan to reduce their holdings by no more than 19668,200 shares, accounting for 3% of the total share capital.